Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $85.59 -1.9%
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.60), $0.15 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $47.81 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
